Tag Archives | biotech portfolios and ETFs

Biotech ETFs Lead Q3 Rally: XBI Breaks Out

Biotech ETFs Are Having A Strong Quarter and Offer Good Investment Options On July 20 we did a review of active funds vs biotech ETFs in the biotechnology/life science sector just after the BREXIT lows. At that time biotech ETFs and broadly diversified funds beat the “pure play” biotechnology funds such as Fidelity Select Biotechnology Portfolio […]

Continue Reading 0

Stealth Biotech Rally With Momentum Rising…Update-1

Update-1…FED Goes on Hold with Rate Increase Likely by Year End Three on FOMC dissented wanting a rate hike this round. Market immediately rallied with NASDAQ up 1.03% at close; S&P and Dow also rally. Biotechs like low i rates:IBB up 0.62% to $297, XBI up 1.14% to $68.28 highest level since January but still […]

Continue Reading 0

Biopharma Stocks Show Resilience in Yo-Yo Week…Update-1

Biopharma Stocks Breeze through ‘Quadruple Witching Day”…9/16 Healthcare stocks (XLV) were one of the leading sectors on a down day up a tiny bit to $72. The IBB held, up 0.57% to the $291 mark and up 4.75% for the week. The more volatile XBI was a tad weaker down 0.3% on the day. Large […]

Continue Reading 0

Healthcare Stocks Lag Market on Drug Pricing…Update-2

Update-2… 945 am EDT…Biotechs Hold Support  IBB up 1.55% to $285 holding support at $280; XBI up 2.99% to $61.95 holding support at $60. Update-1…More Fallout from Mylan (MYL) EpiPen Drug Pricing MYL stock was down over 4% today on news that the EpiPen was mis-classified as a generic drug and that Medicaid was overcharged. […]

Continue Reading 0

Biotech Investors Stung By Drug Pricing Flap…Update-1

Update-1… IBB Trying to hold the $280 line after media bashing of EpiPen Pricing- now they have a generic EpiPen for half the price! Biotech outflows are a concern (-$184M) Gilead Sciences (GILD) down 2.89% on new potential competition from GlaxoSmithK (GSK) HIV double therapy drug with cost savings. Choppy market in biotech with red screen […]

Continue Reading 0

Pfizer (PFE) Acquisition of Medivation (MDVN) Provides Support to Biotech Stocks…Update-1 IBB Down 3.36%

Update-1 After Close 8/24 IBB at 286.23 XBI down 4.34% XLV down 1.54%, NASDAQ down 0.81% Early Afternoon Reversal Kills Biotech Rally In Heavy Trading But Mylan is not a biotech Company?? The broad based rally in biotech stocks faded around 1P EDT Wednesday as investors were spooked by the recurring political theme of high […]

Continue Reading 0

Biotech Breakout Part 2: Hold Your Fire…Update 8/15/16

Update August 15 : Biotech Leads But Healthcare Sector Lags IBB up 0.92% to $295, XBI up 1.33% to $63.35, XLV up 0.17% to $74.91 The tape was pretty decent despite a quiet day with ALXN up 1.97%, AMGN up 1.49% and CELG up 1.08%. Mid-caps also found bids: ALKS up 2.91%,ALNY up 2.16% and […]

Continue Reading 0

Biotech Stocks Strike a Bullish Tone: BLUE, IBB, REGN, SGEN…Update-2

Bullish Tone-Large Cap Biopharmaceutical Earnings Updates 8/5 Regeneron (REGN) shares fell another 2.4% to $423 despite a jump of 23% on Eylea sales to $832M compared to $655 M in the prior-year quarter. Higher expenses cut profitability as GAAP income was up only 1%.Financial results were reported at the close on Wednesday. Full year growth […]

Continue Reading 0

Biotechs Get a Turbo Boost from Biogen(BIIB)…Update-1 GILD

Update-1… Gilead Sciences (GILD) Sells Off on earnings Gilead Sciences (GILD) sold off over 4% after hours after releasing second quarter sales of $7.7B and earnings of $3.08/sh. Q2 profit forecast beat. The full year revenue forecast was also cut slightly by $1B to the $29,5B-$31.5B range. Pricing pressures continued on Hep-C drugs and new […]

Continue Reading 0

Biotech Rally Up 8% from Brexit Bottom: Rayno Biopharmaceutical Portfolio Update: July 11, 2016…Update-1

Update-1… 7/12/16 Dow and S&P Hit Record Highs, Awaiting Q2 Earnings-Risk Still On-Biotech Stocks Lag The market continued its post-BREXIT rally helped by low interest rates and WTI crude up 4.56% to $46.80. Gold eased off and the dollar was up. We are still rallying off last Friday’s job report and Alcoa (AA) earnings yesterday. […]

Continue Reading 0